BPCR.L Sygnały na żywo | Maksymalizuj zyski z Getagraph.com

Live Chart Being Loaded With Signals

Commentary (3 geg. 2024 @ 18:35):

BioPharma Credit PLC, an investment trust, primarily invests in interest-bearing debt assets. Its assets are secured by royalties or other cash flows derived from the sales of approved life sciences products...

Stats
Dzisiejszy wolumen	2.15M
Średni wolumen	1.78M
Kapitalizacja rynkowa	10.74M
EPS	$0 ( 2024-03-27 )
Następna data zysków	( $0 ) 2024-06-12
Last Dividend	$0.0175 ( 2023-08-17 )
Next Dividend	$0 ( N/A )
P/E	10.98
ATR14	$0.00200 (0.23%)

Wolumen Korelacja

Długi: -0.08 (neutral)

Krótki: -0.90 (very strong negative)

Signal:(50.233) Neutral

BioPharma Credit PLC Korelacja

10 Najbardziej pozytywne korelacje

10 Najbardziej negatywne korelacje

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

BioPharma Credit PLC Korelacja - Waluta/Towar

0.00
( neutral )

0.13
( neutral )

0.00
( neutral )

0.27
( neutral )

BioPharma Credit PLC Finanse

Annual	2023
Przychody:	$110.49M
Zysk brutto:	$110.49M (100.00 %)
EPS:	$0.0828

FY	2023
Przychody:	$110.49M
Zysk brutto:	$110.49M (100.00 %)
EPS:	$0.0828

FY	2022
Przychody:	$184.25M
Zysk brutto:	$184.25M (100.00 %)
EPS:	$0.130

FY	2021
Przychody:	$87.97M
Zysk brutto:	$0.00 (0.00 %)
EPS:	$0.0620

Financial Reports:

No articles found.

BioPharma Credit PLC Dividends

(Q3/22)	(Q4/22)	(Q1/23)	(Q2/23)	(Q3/23)	(Q4/23)	(Q1/24)	(Q2/24)	(Q3/24)	(Q4/24)
$0.0175 (N/A)	$0.0450 (N/A)	$0.0158 (N/A)	$0.0175 (N/A)	$0.0175 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)

BioPharma Credit PLC Dividend Information - Dividend Knight

Dividend Sustainability Score: 7.79 - good (77.86%) | Divividend Growth Potential Score: 4.24 - Stable (15.24%)

Very Unsafe

High risk of being cut

Unsafe

Heightened risk of being cut

Borderline

Moderate risk of being cut

Safe

Unlikely to be cut

Very Safe

Very unlikely to be cut

Information

First Dividend	$0.0100	2017-09-28
Last Dividend	$0.0175	2023-08-17
Next Dividend	$0	N/A
Payout Date	0000-00-00
Next Payout Date	N/A
# dividends	25	--
Total Paid Out	$0.385	--
Avg. Dividend % Per Year	1.46%	--
Score	4.14	--
Div. Sustainability Score	7.79
Div.Growth Potential Score	4.24
Div. Directional Score	6.01	--

Next Divdend (Est)
(2024-07-01)

$0.0175 Estimate 21.90 %

Dividend Stability

0.58 Average

Dividend Score

4.14

Pay Frequency

Quarterly

Yearly Payout

Year	Amount	Yield
2017	$0.0200	0.02%
2018	$0.0594	0.06%
2019	$0.0543	0.05%
2020	$0.0479	0.05%
2021	$0.0554	0.06%
2022	$0.0975	0.10%
2023	$0.0508	5.35%
2024	$0	0.00%

Dividend Commentary

The company's strong Dividend Sustainability Score (DSS) indicates its robust capacity to uphold current dividend levels. Unfortunately, its low Dividend Growth Potential Score (DGPS) suggests limited prospects for dividend growth. On the whole, the dividend outlook remains neutral, meriting close observation of both the company's financial health and growth prospects.

Top 10 dividend Companies for LSE

Symbol	Title	Last dividend	Frequency	Years Dividend	Yearly Dividend
VCAP.L	Dividend Knight	2023-09-14	Semi-Annually	4	3.56%
MRCH.L	Dividend King	2023-07-06	Quarterly	53	3.07%
DLN.L	Dividend Knight	2023-09-07	Semi-Annually	32	1.77%
SHG.L	Dividend Knight	2023-11-02	Semi-Annually	4	0.91%
IHP.L	Dividend Knight	2023-06-08	Semi-Annually	7	1.08%
BOCH.L	Dividend Junior	2023-05-04	Insufficient data to determine frequency	2	1.10%
OCN.L	Dividend Knight	2023-05-18	Annually	19	3.96%
ESNT.L	Dividend King	2023-09-21	Semi-Annually	20	4.44%
STAN.L	Dividend Junior	2023-08-10	Annually	32	1.92%
JMAT.L	Dividend Knight	2023-06-08	Semi-Annually	33	1.93%

Dividend Sustainability Score (DSS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
netProfitMarginTTM	0.799	1.500	10.00	10.00	[0 - 0.5]
returnOnAssetsTTM	0.0799	1.200	7.34	8.80	[0 - 0.3]
returnOnEquityTTM	0.0813	1.500	-0.208	-0.312	[0.1 - 1]
payoutRatioTTM	0.828	-1.000	1.722	-1.722	[0 - 1]
currentRatioTTM	9.79	0.800	10.00	8.00	[1 - 3]
quickRatioTTM	9.78	0.800	10.00	8.00	[0.8 - 2.5]
cashRatioTTM	8.51	1.500	10.00	10.00	[0.2 - 2]
debtRatioTTM	0	-1.500	0	0	[0 - 0.6]
interestCoverageTTM	0	1.000	-1.111	-1.111	[3 - 30]
operatingCashFlowPerShareTTM	0.0946	2.00	9.97	10.00	[0 - 30]
freeCashFlowPerShareTTM	0.0946	2.00	9.95	10.00	[0 - 20]
debtEquityRatioTTM	0	-1.500	0	0	[0 - 2.5]
grossProfitMarginTTM	1.000	1.000	10.00	10.00	[0.2 - 0.8]
operatingProfitMarginTTM	0.799	1.000	10.00	10.00	[0.1 - 0.6]
cashFlowToDebtRatioTTM	0	1.000	-1.111	-1.111	[0.2 - 2]
assetTurnoverTTM	0.100	0.800	-2.67	-2.13	[0.5 - 2]
Total Score				7.79

Dividend Growth Score (DGS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
peRatioTTM	10.57	1.000	9.03	0	[1 - 100]
returnOnEquityTTM	0.0813	2.50	-0.134	-0.312	[0.1 - 1.5]
freeCashFlowPerShareTTM	0.0946	2.00	9.97	10.00	[0 - 30]
dividendYielPercentageTTM	11.60	1.500	10.00	0	[0 - 0.4]
operatingCashFlowPerShareTTM	0.0946	2.00	9.97	10.00	[0 - 30]
payoutRatioTTM	0.828	1.500	1.722	-1.722	[0 - 1]
pegRatioTTM	-0.390	1.500	-5.94	0	[0.5 - 2]
operatingCashFlowSalesRatioTTM	0.908	1.000	10.00	0	[0.1 - 0.5]
Total Score				4.24

BioPharma Credit PLC